These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 11799303)
1. [Frequency of the common cold in healthy subjects during exposure to a lectin-rich and a lectin-poor mistletoe preparation in a randomized, double-blind, placebo-controlled study]. Huber R; Klein R; Lüdtke R; Werner M Forsch Komplementarmed Klass Naturheilkd; 2001 Dec; 8(6):354-8. PubMed ID: 11799303 [TBL] [Abstract][Full Text] [Related]
2. Effects of a lectin- and a viscotoxin-rich mistletoe preparation on clinical and hematologic parameters: a placebo-controlled evaluation in healthy subjects. Huber R; Klein R; Berg PA; Lüdtke R; Werner M J Altern Complement Med; 2002 Dec; 8(6):857-66. PubMed ID: 12614536 [TBL] [Abstract][Full Text] [Related]
3. In vivo-induction of antibodies to mistletoe lectin-1 and viscotoxin by exposure to aqueous mistletoe extracts: a randomised double-blinded placebo controlled phase I study in healthy individuals. Klein R; Classen K; Berg PA; Lüdtke R; Werner M; Huber R Eur J Med Res; 2002 Apr; 7(4):155-63. PubMed ID: 12010650 [TBL] [Abstract][Full Text] [Related]
4. Mistletoe treatment induces GM-CSF- and IL-5 production by PBMC and increases blood granulocyte- and eosinophil counts: a placebo controlled randomized study in healthy subjects. Huber R; Rostock M; Goedl R; Lüdtke R; Urech K; Buck S; Klein R Eur J Med Res; 2005 Oct; 10(10):411-8. PubMed ID: 16287602 [TBL] [Abstract][Full Text] [Related]
5. Immunologic effects of mistletoe lectins: a placebo-controlled study in healthy subjects. Huber R; Rostock M; Goedl R; Lüdtke R; Urech K; Klein R J Soc Integr Oncol; 2006; 4(1):3-7. PubMed ID: 16737665 [TBL] [Abstract][Full Text] [Related]
6. Effects of a mistletoe preparation with defined lectin content on chronic hepatitis C: an individually controlled cohort study. Huber R; Lüdtke R; Klassen M; Müller-Buscher G; Wolff-Vorbeck G; Scheer R Eur J Med Res; 2001 Sep; 6(9):399-405. PubMed ID: 11669085 [TBL] [Abstract][Full Text] [Related]
7. In vitro immunoreactivity towards lectin-rich or viscotoxin-rich mistletoe (Viscum album L.) extracts Iscador applied to healthy individuals. Huber R; Classen K; Werner M; Klein R Arzneimittelforschung; 2006 Jun; 56(6A):447-56. PubMed ID: 16927525 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial. Lizogub VG; Riley DS; Heger M Explore (NY); 2007; 3(6):573-84. PubMed ID: 18005909 [TBL] [Abstract][Full Text] [Related]
9. Safety and effects of two mistletoe preparations on production of Interleukin-6 and other immune parameters - a placebo controlled clinical trial in healthy subjects. Huber R; Lüdtke H; Wieber J; Beckmann C BMC Complement Altern Med; 2011 Nov; 11():116. PubMed ID: 22114899 [TBL] [Abstract][Full Text] [Related]
10. Study on local inflammatory reactions and other parameters during subcutaneous mistletoe application in HIV-positive patients and HIV-negative subjects over a period of 18 weeks. Stoss M; van Wely M; Musielsky H; Gorter RW Arzneimittelforschung; 1999 Apr; 49(4):366-73. PubMed ID: 10337457 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of COLD-fX in the prevention of respiratory symptoms in community-dwelling adults: a randomized, double-blinded, placebo controlled trial. McElhaney JE; Goel V; Toane B; Hooten J; Shan JJ J Altern Complement Med; 2006 Mar; 12(2):153-7. PubMed ID: 16566675 [TBL] [Abstract][Full Text] [Related]
12. Absence of tumor growth stimulation in a panel of 16 human tumor cell lines by mistletoe extracts in vitro. Maier G; Fiebig HH Anticancer Drugs; 2002 Apr; 13(4):373-9. PubMed ID: 11984083 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of a standardized echinacea preparation (Echinilin) for the treatment of the common cold: a randomized, double-blind, placebo-controlled trial. Goel V; Lovlin R; Barton R; Lyon MR; Bauer R; Lee TD; Basu TK J Clin Pharm Ther; 2004 Feb; 29(1):75-83. PubMed ID: 14748902 [TBL] [Abstract][Full Text] [Related]
14. Echinaforce and other Echinacea fresh plant preparations in the treatment of the common cold. A randomized, placebo controlled, double-blind clinical trial. Brinkeborn RM; Shah DV; Degenring FH Phytomedicine; 1999 Mar; 6(1):1-6. PubMed ID: 10228604 [TBL] [Abstract][Full Text] [Related]
15. Randomized and double-blind studies--demands and reality as demonstrated by two examples of mistletoe research. Rostock M; Huber R Forsch Komplementarmed Klass Naturheilkd; 2004 Aug; 11 Suppl 1():18-22. PubMed ID: 15353898 [TBL] [Abstract][Full Text] [Related]
16. Prospective controlled cohort studies on long-term therapy of breast cancer patients with a mistletoe preparation (Iscador). Grossarth-Maticek R; Ziegler R Forsch Komplementmed; 2006 Oct; 13(5):285-92. PubMed ID: 17057389 [TBL] [Abstract][Full Text] [Related]
17. Randomized and non-randomized prospective controlled cohort studies in matched pair design for the long-term therapy of corpus uteri cancer patients with a mistletoe preparation (Iscador). Grossarth-Maticek R; Ziegler R Eur J Med Res; 2008 Mar; 13(3):107-20. PubMed ID: 18499556 [TBL] [Abstract][Full Text] [Related]
18. Toxicity of a standardized mistletoe extract in immunocompromised and healthy individuals. van Wely M; Stoss M; Gorter RW Am J Ther; 1999 Jan; 6(1):37-43. PubMed ID: 10423645 [TBL] [Abstract][Full Text] [Related]
19. Larch arabinogalactan effects on reducing incidence of upper respiratory infections. Riede L; Grube B; Gruenwald J Curr Med Res Opin; 2013 Mar; 29(3):251-8. PubMed ID: 23339578 [TBL] [Abstract][Full Text] [Related]
20. Echinacea purpurea therapy for the treatment of the common cold: a randomized, double-blind, placebo-controlled clinical trial. Yale SH; Liu K Arch Intern Med; 2004 Jun; 164(11):1237-41. PubMed ID: 15197051 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]